|

Ovarian Cancer Identification on CT Using Deep Learning

RECRUITINGSponsored by Chang Gung Memorial Hospital
Actively Recruiting
SponsorChang Gung Memorial Hospital
Started2022-09-01
Est. completion2025-02-07
Eligibility
Age20 Years+
SexFEMALE
Healthy vol.Accepted

Summary

Ovarian cancer remains the deadliest gynecologic malignancy, with poor survival rates largely due to late-stage diagnosis. Early detection is crucial, yet no universally accepted screening method exists. Current imaging techniques and biomarkers, such as CA-125, have limitations in specificity and sensitivity. This study aims to develop and evaluate a deep learning-based computer-aided diagnosis tool (CAT-OV), for ovarian cancer detection using CT imaging. The system integrates a Body Part Regression (BPR) model for pelvic localization and a Multiple Instance Learning (MIL) ensemble classifier for cancer prediction. The model was trained and validated using retrospective datasets from Taiwan, the United States, and a nationwide real-world cohort. Stringent preprocessing and quality control measures were implemented to enhance model accuracy. Results highlight the potential of AI-driven CT screening in improving early detection, though further validation is needed for clinical adoption.

Eligibility

Age: 20 Years+Sex: FEMALEHealthy volunteers accepted
Inclusion Criteria:

1. Age ≥ 20 years old.
2. Female
3. undergone a CT scan
4. undergone a CT scan within 180 days prior to ovarian surgery for histopathological evaluation.

Exclusion Criteria:

1. Age \< 20 years old.
2. Non-female
3. Non-CT imaging
4. Incorrect image orientation
5. Number of slices \< 10
6. Slice thickness \>10 mm or \< 1 mm
7. Unsuccessful DICM-to-NIfTI
8. Pelvic subvolume extraction failed
9. Non-contrast CT scans
10. Metallic artifacts
11. Inconclusive cases

Conditions2

CancerOvarian Cancer

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.